Breaking: FDA investigating whether CAR-T can cause lymphoma

An FDA investigation into links between CAR-T immunotherapy and new cancers comes as a surprise to many scientists in the field.

Log In    Try STAT+ FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma By Angus Chen, Matthew Herper, and Jason Mast Illustration: STAT; Source: Business Wire The FDA said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.    Experts in the field expressed surprise and puzzlement at the announcement, saying that they hadn't previously seen data about the risk. READ THE STORY In Case You Missed It Special Report 'How do you decide?': Cancer treatment's CAR-T crisis has patients dying on a waitlist Biotech Springworks wins FDA approval for drug to treat desmoid tumors Politics To get things done fast at FDA: 'Don't tell anybody,' cancer chief says ALL STORIES STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences   |   Contact Us   |   Advertise With Us